Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: J Chem Inf Model. 2012 May 29;52(6):1637–1659. doi: 10.1021/ci300009z

Table 6.

CYP-mediated pathway propensities (%) according to the #ofoxidizedSOMs#potentialSOMs of known substrates of each isozyme. Similar pathways, or those with low relative populations such as Csp2-based reactions (B), are grouped together in order to simplify pathway-based performance analysis in Figure 3

Pathway 1A2 2A6 2B6 2C19 2C8 2C9 2D6 2E1 3A4 merged

Csp3 Hydroxylation 13.0 11.3 9.9 10.9 10.8 15.7 9.0 14.5 10.8 13.9
Aromatic Hydroxylation 16.1 11.0 12.3 7.6 10.9 12.8 10.7 18.2 10.3 14.1
Ring Hydroxylation 14.1 20.0 8.4 10.4 11.8 9.0 9.1 14.2 10.5 11.9
O-dealkylation 48.1 48.5 39.3 51.8 34.9 48.5 50.0 45.8 31.0 48.9
N-dealkylation 43.1 48.5 44.0 38.7 46.7 35.8 29.6 39.2 44.7 43.4
Sulfur(II) Oxidation (A) 50.0 73.3 66.7 53.3 47.0 61.1 57.9 58.8 59.7 54.4
Sulfur(IV) Oxidation (A) 100 0.0 100 42.9 0 33.3 100 None 100 90.9
Desulfuration (A) 66.7 0.0 50.0 57.1 42.9 40.0 75.0 100 40.0 36.4
Csp2 Oxidation (B) 17.4 20.0 18.2 15.7 19.4 20.9 5.4 17.8 8.5 20.4
Aldehyde Oxidation (B) 100 100 100 100 100 100 100 75.0 71.4 70.0
Alcohol Oxidation (B) 29.4 66.7 14.3 13.6 13.6 23.8 9.7 14.3 9.6 9.2
N-hydroxylation (C) 9.0 15.2 7.1 7.0 7.6 5.6 7.0 13.0 5.4 8.7
N-oxide Formation (C) 3.0 2.6 0 1.9 3.8 2.4 3.4 5.3 4.2 4.5
Nitro-group Reduction (C) 21.4 0 0 0 0 0 0 14.3 5.9 18.2
Dehalogenation (C) 3.6 8.1 2.8 0 1.6 0 1.1 17.6 1.3 3.3
Uncommon 0.6 1.0 0.8 0.6 1.2 0.4 0.6 1.0 0.6 0.8
Overall 12.1 12.5 10.6 9.2 10.2 10.3 9.5 13.6 9.2 11.3